ORA SYSTEM WITH VERIFEYE MESSAGING
Report
- Report Number
- 2028159-2024-01575
- Event Type
- Injury
- Date Received
- October 17, 2024
- Date of Event
- July 2, 2024
- Report Date
- December 27, 2024
- Manufacturer
- ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
- Product Code
- NCF
- PMA / PMN Number
- EXEMPT
- Removal / Correction Number
- NA
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- 003
Narratives
ADDITIONAL INFORMATION PROVIDED IN H.3., H.6., AND H.11. ALL DEVICE HISTORY RECORDS ARE REVIEWED PRIOR TO PRODUCT RELEASE TO ENSURE THE PRODUCT WAS MANUFACTURED IN COMPLIANCE WITH THE DEVICE MASTER RECORD AND MEETS RELEASE CRITERIA. BASED ON THE INFORMATION OBTAINED, THE ROOT CAUSE OF THE REPORTED EVENT IS INCONCLUSIVE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.
H.3., H.6.: INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS IMPLANT, THE PATIENT WAS UNABLE TO TOLERATE THE MULTIFOCAL LENS. THE PATIENT EXPERIENCED SIGNIFICANT GLARE IN THE LEFT EYE, ALONG WITH DISCREPANCIES IN THE INTRAOCULAR LENS CALCULATIONS IN THE SYSTEM, WHICH RESULTED IN AN UNEXPECTED HYPEROPIC OUTCOME AFTER CATARACT SURGERY. ADDITIONALLY, THE PATIENT REPORTED ISSUES WITH GLARE, HEADACHES, AND NAUSEA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1368092 | ORA SYSTEM WITH VERIFEYE MESSAGING | ABERROMETER, OPHTHALMIC | NCF | ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Male | Other| R | CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR.| CLAREON PANOPTIX TORIC TRIFOCAL HYDROPHOBIC IOL.| CLAREON TORIC IOL.| MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D. |